What the human research shows
A consistent small signal from small trials. Grade C: the pooled result is statistically clear, the studies behind it are not big enough to be sure of the size, and the mechanism problem — an enzyme in blood that destroys it — is unresolved.
Evidence profile0–5
- Metabolic & weightC0.7
- Cardiovascular—0.0
- Muscle & growth—0.0
- Healing & repair—0.0
- Neuro & sleep—0.0
- Immune & inflammation—0.0
- Sexual & hormonal—0.0
- Skin & appearance—0.0
- Ageing & longevityD0.0
| Outcome | Grade | Effect size | Human studies | Where the evidence comes from |
|---|---|---|---|---|
| Blood glucose (fasting glucose and HbA1c) in prediabetes and type 2 diabetes | CWeak | Small | 8 RCTs (n=377) pooled | Standardised mean differences of about half a standard deviation for fasting glucose and a third for HbA1c against placebo. Trials of 12–14 weeks; several at high risk of bias.1 |
| Body weight and insulin resistance | CWeak | Not measurable | Same meta-analysis | No effect on BMI, fasting insulin or HOMA-IR; a small fall in total cholesterol.1 |
| Cognition or ageing | DNo human evidence | Not measurable | No adequate trial | The anti-ageing use rests on animal and cell work on glycation and oxidative stress; no controlled human trial of an ageing endpoint exists.2 |
Literature searched to 23 September 2026. Human studies only; animal and cell work informs the mechanism section and nothing else.
Registered trials
ClinicalTrials.gov lists 37 interventional studies naming Carnosine as an intervention — 25 completed, 1 recruiting, and 4 with results posted to the registry.
A registration is not a result. Anyone can register a study, and many never report — so this list shows what has been attempted, not what has been shown. The graded evidence above is the answer to whether something works.
| Study | Phase | Status | Participants | Sponsor | Results |
|---|---|---|---|---|---|
| Treatment Study of Carnosine Versus Placebo in Gulf War Illness (GWI)NCT00810368 · started Aug 2008 | Phase 2 | Completed | 33 | Georgetown University | Posted |
| Nucleophilic Defense Against PM Toxicity (NEAT Trial)NCT03314987 · started Apr 2018 | N/A | Completed | 299 | University of Louisville | Posted |
| Carnosine Loading and Periodized Training in MS and HCNCT03418376 · started Feb 2017 | N/A | Completed | 45 | Hasselt University | Posted |
| Creatine, Carnitine and Carnosine in VegetariansNCT03194334 · started Dec 2012 | N/A | Completed | 40 | University Ghent | Posted |
| Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux DiseaseNCT03467438 · started Nov 2018 | Phase 4 | Unknown | 80* | Fondazione IRCCS Policlinico San Matteo di Pavia | None |
| The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60sNCT03111979 · started Apr 2014 | Phase 4 | Suspended | 24* | Nottingham Trent University | None |
| β-alanine Supplementation on Knee Extensor Contractile and Force PropertiesNCT02819505 · started Dec 2014 | Phase 4 | Completed | 23 | Nottingham Trent University | None |
| Efficacy of Zinc L-Carnosine Mouth RinseNCT04430998 · started Jun 2020 | Phase 3 | Unknown | 75* | University of Milan | None |
29 further studies are registered. Participant counts marked * are the sponsor's estimate, not a final enrolment. Source: ClinicalTrials.gov, read directly from the registry and refreshed weekly.
What it is
Carnosine is made in muscle from beta-alanine and histidine, where it buffers acid during intense exercise — which is why beta-alanine, its rate-limiting precursor, is a sports supplement. It is also a scavenger of reactive carbonyls and an anti-glycation agent in the laboratory, the basis of its ageing and diabetes claims.
How it is thought to work
Proposed actions are anti-glycation, antioxidant and acid buffering. The complication is serum carnosinase, an enzyme that hydrolyses carnosine in human blood within minutes; how much of a swallowed dose reaches muscle or brain intact is unclear, and the glucose effect may run through the metabolites.
What is still unknown
- Effect size in a properly powered trial; the eight trials total under 400 people.
- Whether intact carnosine or its breakdown products are responsible.
The molecule and how long it lasts
- Formula
- C9H14N4O3
- Molecular weight
- 226.23 g/mol
- CAS number
- 305-84-0
- PubChem
- CID 439224
PubChem record, read 23 September 2026.
- Route
- Oral
- Half-life
- No half-life figure recorded by LYO; carnosine is hydrolysed in blood by serum carnosinase, which is why plasma levels are hard to sustain
No pharmacokinetic study in people.
Regulatory status
Sold as food; no authorised health claim.
Sold under DSHEA.
Food law.
Depending on presentation.
NPN products exist.
Not on the Prohibited List; beta-alanine is likewise permitted.
Questions people actually ask
Does carnosine lower blood sugar?
Is carnosine the same as carnitine?
Is carnosine a peptide?
One page per claimed effect
- CDoes Carnosine help with blood glucosein prediabetes and type 2 diabetes?8 RCTs (n=377) pooled
- CDoes Carnosine help with body weight and insulin resistance?Same meta-analysis
- DDoes Carnosine help with cognition or ageing?No adequate trial
References
- 1Li N, et al. Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.BMC Endocr Disord, 20258 trials, 377 participants.
- 2
Change log
- 2026-09-23Initial publication. Grade C on the 2025 meta-analysis.